Purpose

The purpose of Medical Affairs is to provide and gather scientific insights to/from internal and external stakeholders, and generate data that translates into clear, compelling and strategic scientific exchange and medical education programs. These will impact recommendations, guidelines and medical practice in order to have a positive impact on health.

The Medical Expert Manager (MEM) is a hybrid role spending 50% of time in the field responsible for providing medical & scientific information, medical education as well as medical insight generation for the influenza, travel vaccine landscape as well as Seqirus licensed and the late-stage portfolio of vaccines. The region of responsibility will focus primarily on the South-East of Germany (Bavaria). For the other 50% of time the MEM will support the Senior Medical Manager in developing and executing the medical strategy for the beforementioned products.

The role interfaces with other functions within Medical Affairs and across the organisation in Commercial, Regulatory, Market Access and other cross functional teams to ensure collaborative connectivity, and a focused medical approach to supporting country and regional business objectives. The MEM will contribute to the implementation of objectives by supporting development and execution the medical strategy for one or more products within the portfolio.

This role aims to build credible and durable relationships with health care professionals (in particular key opinion leaders) and other relevant external stakeholders.

The MEM will also support the medical teams within CSL in other countries especially within the DACH region (Germany, Austria, Switzerland).

Accountabilities

• Communicate new and other important approved medical content to targeted Health Care Professionals (HCPs) in local, regional or national capacities including Vaccines HCP decision-makers, national and regional Key Opinion Leaders (KOLs), national and regional professional associations, payer’s groups at regional and national level, government organizations, primary care key stakeholders at regional level and any other HCP who may be considered an influencer for flu protection in Germany.

• Work closely in the local medical team to ensure generated insights are captured, shared and escalated as needed.

• Provide internal product and indication expertise for any Seqirus/CSL colleague (e.g. field force training, develop and update medical slides, medical review and copy clearance, etc.).

• Engage and collaborate with Marketing, Market access, Policy, Sales Team, Customer Services, Communications at a local level and Medical Affairs teams at regional EMEA and when necessary, at a global level.

• Develop and maintain in-depth medical science expertise for designated disease area and products, including analysis of current literature, opinion and recommendations.

• Be a proactive and strategic member of designated brand/business cross-functional teams.

Requirements

• A Master in Biological Science, Medical or Clinical discipline or Pharmacy with complementary experience in the pharmaceutical/ biotechnology/ healthcare industry preferably in vaccines; PhD in relevant field or MD preferred

• Experience in clinical and/or health services education or research (preferably in the pharmaceutical industry).

• Experience with clinical research and/or pharmaceutical industry as MSL, Medical Advisor or other relevant position

• Experience in influenza, infectious diseases, epidemiology, vaccines, public health and the German health care system

• Fluent in English and German

• Holds a driving license valid in Germany

• Willing to travel across Germany and internationally according to business needs

• Required to be flexible in working hours

Our Benefits

CSL Seqirus is committed to attracting and retaining world-class employees who are valued for their contributions to achieving business objectives. Learn more about some of the benefits you can participate in when you join CSL Seqirus.

About CSL Seqirus

CSL Seqirus is part of CSL . As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.

We want Seqirus to reflect the world around us

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL.

Do work that matters at CSL Seqirus!

Watch our ‘On the Front Line’ video to learn more about CSL Seqirus